Literature DB >> 33157113

Optical coherence tomography angiography in neuro-ophthalmology: Current clinical role and future perspectives.

Amar Pujari1, Karthika Bhaskaran2, Pradeep Sharma2, Pallavi Singh2, Swati Phuljhele2, Rohit Saxena2, Shorya Vardhan Azad2.   

Abstract

Optical coherence tomography angiography (OCTA) is a noninvasive, depth-resolved imaging tool for the appraisement of retinal vascular changes. Since its introduction, the understanding of diabetic retinopathy, age-related macular degeneration, central serous retinopathy, and other diseases has been enriched on many fronts. Its dyeless imaging property maps retinal as well as deeper choroidal vasculature in quick succession with good reproducibility. Hence, it can play an important role in the diagnosis and management of optic nerve-related diseases as well. A detailed literature review for its role in nonarteritic anterior ischemic optic neuropathy, papilledema, optic disc drusen, papillitis, hereditary optic neuropathies, central nervous system diseases, and others highlights its role. The whole spectrum of neuro-ophthalmological diseases shows consistent peripapillary and macular capillary changes with structural and functional correlation. The superficial and deeper retinal and choroidal vasculatures are affected depending on the nature of the disease process. Hence, OCTA positions itself as a useful, noninvasive tool in the armamentarium of a neuro-ophthalmologist in future; however, there are several limitations of the OCTA with respect to its technical abilities in challenging neuro-ophthalmic cases. Therefore, future research should be directed to enhance the technical capabilities of OCTA and to determine the more precise role of it in the prognosis of neuro-ophthalmic diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease and OCTA; LHON and OCTA; ischemic optic neuropathy and OCTA; multiple sclerosis and OCTA; neurodegenerative diseases and OCTA; optic disc drusen and OCTA; optic nerve head optical coherence tomography angiography; optical coherence tomography angiography; papilledema and OCTA; papillitis and OCTA

Mesh:

Year:  2020        PMID: 33157113     DOI: 10.1016/j.survophthal.2020.10.009

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  6 in total

1.  Quantification of peripapillary vessel density in non-arteritic anterior ischemic optic neuropathy patients with optical coherence tomography angiography.

Authors:  Yufang Su; Song Zhang; Guisen Zhang; Yingru Liu; Zhiguo Du; Daming Li; Lei Liu
Journal:  Quant Imaging Med Surg       Date:  2022-02

2.  Reduced Superficial Capillary Density in Cerebral Infarction Is Inversely Correlated With the NIHSS Score.

Authors:  William Robert Kwapong; Yuying Yan; Zilong Hao; Bo Wu
Journal:  Front Aging Neurosci       Date:  2021-02-25       Impact factor: 5.750

3.  Long-term repeatability of peripapillary optical coherence tomography angiography measurements in healthy eyes.

Authors:  Woo Hyuk Lee; Min-Woo Lee; Min-Su Kim; Cheon Kuk Ryu; Jung-Yeul Kim
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

Review 4.  Enhanced medical diagnosis for dOCTors: a perspective of optical coherence tomography.

Authors:  Rainer Leitgeb; Fabian Placzek; Elisabet Rank; Lisa Krainz; Richard Haindl; Qian Li; Mengyang Liu; Marco Andreana; Angelika Unterhuber; Tilman Schmoll; Wolfgang Drexler
Journal:  J Biomed Opt       Date:  2021-10       Impact factor: 3.758

Review 5.  The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases.

Authors:  Serdar Bilici; Reşat Duman
Journal:  Taiwan J Ophthalmol       Date:  2022-02-11

6.  Topographic Quadrant Analysis of Peripapillary Superficial Microvasculature in Optic Disc Drusen.

Authors:  Yan Yan; Xiao Zhou; Zhongdi Chu; Laurel Stell; Mohammad Ali Shariati; Ruikang K Wang; Yaping Joyce Liao
Journal:  Front Neurol       Date:  2021-05-19       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.